CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Food and Drug Administration last week approved one-day dosing of the herpes treatment Famvir to treat recurrent genital herpes and cold sores in people with healthy immune systems. Previously, treating genital herpes required five days of Famvir treatment at a lower dose. The drug was not previously approved to treat cold sores, which also are caused by a common herpes virus. Now treatment of genital herpes can be completed with two 1,000-milligram doses of Famvir taken during just one day immediately after the outbreak of herpes symptoms. Cold sores are treated with a single 1,500-milligram dose. The Centers for Disease Control and Prevention estimates that about 45 million Americans over age 12 have genital herpes, which is an incurable sexually transmitted disease. (The Advocate)
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Meet all 37 of the queer women in this season's WNBA
April 17 2024 11:24 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
21+ steamy photos of Scotland’s finest gay men in Elska Glasgow
February 01 2024 10:07 PM
More Than 50 of Our Favorite LGBTQ+ Moms
May 12 2024 11:44 AM
Conjoined twins Lori Schappell and trans man George Schappell dead at 62
April 27 2024 6:13 PM
Latest Stories
Chino Valley school district sues California over new law banning forced outing
July 18 2024 6:52 PM
Federal appeals court upholds Tennessee drag ban
July 18 2024 5:41 PM
While the Lord Almighty speaks to Biden, it’s time to prepare for Harris
July 18 2024 3:22 PM
Yemi Alade, Billy Porter and Omawumi to headline Global Black Pride 2024 in Atlanta
July 18 2024 2:57 PM
Ruby Corado, founder of LGBTQ+ nonprofit Casa Ruby, pleads guilty to wire fraud
July 18 2024 10:23 AM
Watch: GLAAD national ad features terrifying potential future under Project 2025
July 18 2024 9:00 AM